Free Trial

PIPELINE: $2B China 2Pt US$ Debt Issuance Launched

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 11/13 $2B #People's Republic of China $1.25B 3Y +1, $750M 5Y +3
  • 11/13 $Benchmark BP Capital PerpNC10 6.375%a
  • 11/13 $Benchmark Swedbank 5Y +90a, 5Y SOFR
  • 11/13 $Benchmark BNY Mellon 11NC10 +100a
  • 11/13 $Benchmark Bank of NY Mellon 11NC10 +100a
  • 11/13 $Benchmark Huntington Ingalls Industries 5Y +140a, 10Y +165a
  • 11/13 $Benchmark Gilead 5Y +75a, +10Y +95a, 30Y +115a, 40Y +125a
  • 11/13 $Benchmark Cardinal Health 2Y +65a, 5Y +90a, 10Y +120a, 30Y +140a
70 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • Date $MM Issuer (Priced *, Launch #)
  • 11/13 $2B #People's Republic of China $1.25B 3Y +1, $750M 5Y +3
  • 11/13 $Benchmark BP Capital PerpNC10 6.375%a
  • 11/13 $Benchmark Swedbank 5Y +90a, 5Y SOFR
  • 11/13 $Benchmark BNY Mellon 11NC10 +100a
  • 11/13 $Benchmark Bank of NY Mellon 11NC10 +100a
  • 11/13 $Benchmark Huntington Ingalls Industries 5Y +140a, 10Y +165a
  • 11/13 $Benchmark Gilead 5Y +75a, +10Y +95a, 30Y +115a, 40Y +125a
  • 11/13 $Benchmark Cardinal Health 2Y +65a, 5Y +90a, 10Y +120a, 30Y +140a